Isabel Healthcare's mission is to
improve the quality of patient care by providing clinicians with
decision support and knowledge to reduce diagnosis errors.
Isabel Healthcare is a fast growing, venture capital backed company operating on a global basis. The company is best known for Isabel, an award-winning Web-based, diagnosis decision support system called Isabel which uses cutting edge technology from Autonomy, an industry leader in Meaning Based Computing (MBC) coupled with proprietary Isabel
algorithms to 'understand' vast amounts of medical knowledge. This
enables the system to instantly provide the busy clinician with a safe
checklist of likely diagnoses for a set of signs and symptoms entered
in free text. The clinicians who 'Isabel'
their patients at an early stage are able to offer a higher quality of
care and reduce clinical risk by ensuring that important possible
diagnoses have not been missed.
Using the same proprietary technology which powers the diagnosis reminder system, Isabel
also mobilizes knowledge to help the clinician find relevant and
diagnosis specific answers to clinical questions more easily and
quickly at the point of care.
As well as helping clinicians provide the highest quality standard of care, Isabel
has set new standards for the clinical testing of decision support
systems in healthcare having undergone a robust, peer-reviewed
validation process over 7 years to demonstrate its accuracy,
effectiveness and value. To date, 13 articles including independent
clinical studies, multi-centre collaborative studies, and our own
studies as developers have appeared in prestigious peer-reviewed
journals.
Isabel uniquely adds intelligence to
the electronic medical record (EMR) by processing extracted relevant
clinical information automatically thereby providing the clinician with
diagnosis support instantly with no additional data entry. To date, Isabel
interfaces with NextGen, PatientKeeper and A4 Health Systems, along
with a number of hospital-based EMR vendors including Cerner.
Jason and Charlotte Maude founded Isabel
Healthcare in July 1999 together with Joseph Britto MD. Dr. Britto was
the Attending Physician on the Pediatric Intensive Care Unit (PICU) at
St Mary’s Hospital in Paddington, London that handled the Maude's
three-year old daughter's care after she was nearly fatally
misdiagnosed by her local hospital. Isabel spent two months in the hospital, including a month in the PICU after experiencing multiple organ failure and cardiac arrest.
Isabel’s
extensive suffering could have been avoided if the local emergency
department and family physicians had stopped to ask 'what else might
this be?' rather than assuming her symptoms as typical of the chicken
pox from which she was also suffering. Isabel
was later diagnosed by Dr. Britto to be suffering from well described
complications of chicken pox-Toxic Shock Syndrome and Necrotising
Fasciitis.
Rather than suing the hospital for the error, Jason Maude teamed up with Dr. Joseph Britto, who conceived the structure of the Isabel and has led the development of the Isabel clinical diagnosis decision support system. Isabel Healthcare was created, in honor of Isabel
Maude and all patients whose lives have been impacted by missed or
delayed diagnosis, to help clinicians around the world reduce cognitive
diagnostic errors.
After two years of research and validation led by P. Ramnarayan MD the pediatric version of the Isabel
diagnostic tool was launched in June 2002. With support from the UK
Department of Health, the UK National Health Service and other key
medical institutions, Isabel quickly gained credibility and support from around the world.
Within months of its launch, the system attracted more than 20,000
users from over 100 countries. Impressed with the system's high levels
of speed and accuracy, demand rapidly grew for an adult version which
was launched in January 2005 and is now used by many top-rated
hospitals in the United States and around the world
Joseph Britto MD.
Chief Executive Officer and Co-founder, Isabel Healthcare, Inc.
As Chief Executive Officer and Co-founder of Isabel
Healthcare, Inc., Dr. Joseph Britto brings more than 15 years of
extensive medical knowledge to the company. Dr. Britto earned his
Doctorate in Pediatrics in 1990 from the medical school at Bombay
University. Three years later, as a Fellow and Lecturer at Imperial
College School of Medicine at St. Mary's Hospital, Dr. Britto developed
and validated England's first model of specialized inter-hospital
transport of critically ill children. This resulted in greatly improved
outcomes of hundreds of critically ill children transported each year.
Dr. Britto's distinguished career continued and in 1996 he was
recognized with the prestigious appointment of Attending Physician and
Senior Lecturer. As a leading member of the pediatric intensive care
team, Dr. Britto brought about dramatic reductions in the mortality
rate of life threatening infections in critically ill children.
After caring for Isabel Maude in 1999, Dr. Britto co-founded Isabel Healthcare with Jason Maude and conceived the structure of the Isabel clinical diagnosis decision support system. Committed to leading the clinical, development and technical aspects of Isabel Healthcare, Dr. Britto chose to leave his distinguished clinical and academic career.
Dr. Britto has published more than 50
peer-reviewed papers and lectured extensively about pediatric critical
care, life threatening infections, diagnosis errors and diagnosis
decision support.
Dr. Joseph Britto is based in Reston, Virginia.
Jason Maude
Chief Executive Officer and Co-founder, Isabel Healthcare Ltd, UK.
Jason Maude serves as Chief Executive Officer and Co-founder of Isabel Healthcare Ltd. Prior to co-founding Isabel
Healthcare Ltd, Maude spent 12 years working in the finance and
investment banking industry in Europe. Throughout his career, Maude
served as a top-ranked equity analyst at Kleinwort Benson Securities,
Smith Barney and Dillon Read. While at Dillon Read, a prestigious U.S.
investment bank, Maude served as partner and managing director of the
company's UK office. This prominent position led Maude to AXA
Investment Managers where he lead equity research and managed $500
billion global investment initiatives.
In 1999, Maude's three-year-old daughter, Isabel fell seriously ill, as a result of a misdiagnosis. Isabel's illness and experience inspired Maude to create Isabel Healthcare.
Jason Maude is based in Haslemere, UK.
P. Ramnarayan, MRCPCH, MD Head of Research and Validation, Isabel Healthcare, Inc.
Dr. Ramnarayan joined Isabel Healthcare in 2000 after establishing the well-known Ram's Teaching Website, now at Medic Central. At Isabel, he has led the extensive and ground-breaking validation process to ensure Isabel's accuracy and ongoing capabilities.
Ramnarayan
earned his M.D. from Imperial College and is currently an Attending
Physician at Great Ormond Street Hospital for Children and St. Mary's
Hospitals in London.
Amanda Tomlinson Head of Content Management, Isabel Healthcare, Inc.
Amanda Tomlinson has been with Isabel
Healthcare for nearly seven years. She joined the Company in 2000 after
spending five years as a senior staff nurse on the Pediatric Infectious
Disease ward at one of London's top hospitals. Tomlinson is focused on
the development of the proprietary database, the tutored taxonomy and
validation.
Natalie Cronje (Registered Dietitian) Research Assistant, Isabel Healthcare, Inc.
Natalie Cronje has been with Isabel Healthcare since 2004.
Prior to joining Isabel Healthcare she worked as a private practising
Dietitian and lecturer at a prominent university in South Africa.
Cronje is focused on validation, research and continued development
of Isabel to ensure accuracy.
Dr. Mike Lynch, OBE Founder and Chief Executive Officer, Autonomy
Studied
Engineering at Cambridge University and obtained a PhD in mathematical
computing. He is a technology entrepreneur and has founded a number of
technology companies including the software company Autonomy
plc where he currently serves as CEO. He has held a number of advisory
and board roles in the venture capital industry and is currently a
non-executive director of Isabel
Healthcare. He was named the Confederation of British Industry's
Entrepreneur of the Year, won an IEE Award for Outstanding Achievement
and was awarded an OBE for Services to Enterprise. He is also a Lady
Margaret Beaufort Fellow of Christ's College, Cambridge. He also serves
on the executive board of the British Broadcasting Corporation (BBC).
Terry Hughes Partner, Silver Point Europe
Silver
Point Europe is a multi-billion dollar credit investment fund where
Hughes heads the Principal Finance business.Prior to this he was a
partner at Goldman Sachs where, over a ten year career, he undertook a
variety of roles including heading the leveraged finance and private
equity sponsor businesses within Europe. He was closely involved in
many of the then defining deals such as financing of Vodafone's bid for
Mannesmann and the original funding for the establishment of Orange. He
also sat on Goldman Sach's Commitments Committee.
Ivan Briery Co-founder of Voltaire Asset Management, London
Co Founder of Voltaire Asset Management, London -one of the UK's top
performing equity hedge funds during 1998-2002 and formally a partner
in Soros Funds.
Juerg Schaeppi CEO, Bank am Bellevue, Zurich, Switzerland
The Bellevue group is one of the world's leading healthcare
investors managing $2 bn assets in BB Biotech and $1 bn in BB Medtech.
Dr. Joseph Britto CEO and Co-founder, Isabel Healthcare, Inc.
As Chief Executive Officer and Co-founder of Isabel
Healthcare, Inc., Dr. Joseph Britto brings more than 15 years of
extensive medical knowledge to the company. Dr. Britto earned his
Doctorate in Pediatrics in 1990 from the medical school at Bombay
University. Three years later, as a Fellow and Lecturer at Imperial
College School of Medicine at St. Mary's Hospital, Dr. Britto developed
and validated England's first model of specialized inter-hospital
transport of critically ill children. This resulted in greatly improved
outcomes of hundreds of critically ill children transported each year.
Dr. Britto's distinguished career continued and in 1996 he was
recognized with the prestigious appointment of Attending Physician and
Senior Lecturer. As a leading member of the pediatric intensive care
team, Dr. Britto brought about dramatic reductions in the mortality
rate of life threatening infections in critically ill children.
After caring for Isabel Maude in 1999, Dr. Britto co-founded Isabel Healthcare with Jason Maude and conceived the structure of the Isabel clinical diagnosis decision support system. Committed to leading the clinical, development and technical aspects of Isabel Healthcare, Dr. Britto chose to leave his distinguished clinical and academic career.
Dr. Britto has published more than 50 peer-reviewed papers and
lectured extensively about pediatric critical care, life threatening
infections, diagnosis errors and diagnosis decision support.
Dr. Joseph Britto is based in Reston, Virginia.
Jason Maude CEO and Co-founder, Isabel Healthcare Ltd.
Jason Maude serves as Chief Executive Officer and Co-founder of Isabel Healthcare, Ltd. Prior to co-founding Isabel
Healthcare Ltd., Maude spent 12 years working in the finance and
investment banking industry in Europe. Throughout his career, Maude
served as a top-ranked equity analyst at Kleinwort Benson Securities,
Smith Barney and Dillon Read. While at Dillon Read, a prestigious U.S.
investment bank, Maude served as partner and managing director of the
company's UK office. This prominent position led Maude to AXA
Investment Managers where he lead equity research and managed $500
billion global investment initiatives.
In 1999, Maude's three-year-old daughter, Isabel fell seriously ill, as a result of a misdiagnosis. Isabel's illness and experience inspired Maude to create Isabel Healthcare, Ltd.
